title: Nontuberculous mycobacterial adenitis: effectiveness of chemotherapy following incomplete excision.
abstract: BACKGROUND
  Management of lymphadenopathy caused by nontuberculous mycobacteria (NTM) is primarily surgical. Where this cannot achieve sufficient clearance of infected nodes, chemotherapy is often given.
  
  
  OBJECTIVE
  This study compared results of surgery alone with surgery followed by chemotherapy in instances where there was incomplete surgical removal of diseased tissue.
  
  
  METHODS
  Chemotherapy comprised azithromycin 10 mg/kg and rifabutin 6 mg/kg both given once daily for 6 mo. Ninety-eight children with NTM infection were seen in the period 1990-2004. Sixty-eight cases with adenopathy where "time to healing" (discharge stopped and inflammation settled) was known were available to compare response to treatment.
  
  
  RESULTS
  The median (range) "time to healing" in weeks for 43 patients who had surgery alone was: incision and drainage (I&D)/curettage 6 (1-72) (n = 10); excision 3 (1-28) (n = 22); and from the last operation of multiple (repeat) surgery 3 (1-40) (n = 11). For 25 patients who required chemotherapy in addition to surgery, the median (range) "time to healing" in weeks was I&D/curettage 10 (1-40) (n = 17), excision 14 (8-20) (n = 2) and multiple surgery 29 (2-88) (n = 6).
  
  
  CONCLUSIONS
  In children with adenitis due to NTM, where surgical resection is followed by continued discharge and inflammation, chemotherapy should be considered before further surgery is undertaken.
authors.affiliation: Royal Liverpool Children's NHS Trust, Alder Hey, Liverpool, UK. j.b.s.coulter@liv.ac.uk
authors.forename: J Brian S
authors.initials: JB
authors.lastname: Coulter
authors.forename: David A
authors.initials: DA
authors.lastname: Lloyd
authors.forename: Matthew
authors.initials: M
authors.lastname: Jones
authors.forename: John C
authors.initials: JC
authors.lastname: Cooper
authors.forename: Maxwell S
authors.initials: MS
authors.lastname: McCormick
authors.forename: Raymond W
authors.initials: RW
authors.lastname: Clarke
authors.forename: Mohommed I
authors.initials: MI
authors.lastname: Tawil
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D017963:Azithromycin / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D005121:Extremities; D005145:Face; D005260:Female; D006801:Humans; D007717:Knee; D008199:Lymphadenitis / Q000188:drug therapy / Q000382:microbiology / Q000601:surgery; D008297:Male; D009161:Mycobacterium / Q000302:isolation & purification*; D009333:Neck; D010306:Parotid Gland; D011182:Postoperative Care; D017828:Rifabutin / Q000627:therapeutic use; D013997:Time Factors; D014945:Wound Healing
chemical_list: D000900:Anti-Bacterial Agents; D017828:Rifabutin; D017963:Azithromycin